ID
31435
Descrição
LOCALIZED PROSTATE CANCER DATA COLLECTION Version 2.0.5 Revised: April 7th , 2017 www.ichom.org ICHOM Localized Prostate Cancer Standard Set was made possible only through the support of the Movember Foundation, an organization changing the face of men’s health. Conditions: Localized prostate cancer Treatment Approaches: Active Surveillance | Watchful Waiting | Radical Prostatectomy* | External Beam Radiation Therapy* | Androgen Deprivation Therapy (ADT)* | Focal Therapy* | Other* * These should also be collected as salvage treatments where necessary This ODM-file contains Baseline Clinical Form. To be used at baseline, i.e., post-diagnosis, pre-treatment. Please timestamp all variables. Some Standard Set variables are collected at multiple timepoints, and we will ask you to submit these variables in a concatenated VARIABLEID_TIMESTAMP form for future analyses. TEST StudyFor example, VARIABLEID_BASE (baseline); VARIABLEID_6MO (6 month follow-up); VARIABLEID_1YR (1 year follow-up), etc. Survey used: Expanded Prostate Cancer Index Composite (EPIC-26): The EPIC-26 is free for all health care organizations, and a license is not needed. The scoring guide may be found at http://www.med.umich.edu/urology/research/EPIC/EPIC-26-Scoring-1.2007.pdf ; Wei J, Dunn R, Litwin M, Sandler H, and Sanda M. "Development and Validation of the Expanded Prostate Cancer Index Composite (EPIC) for Comprehensive Assessment of Health-Related Quality of Life in Men with Prostate Cancer", Urology. 56: 899-905, 2000. For registries choosing to implement the EPIC-CP rather than the EPIC-26, we recommend using the same variable IDs as the corresponding EPIC-26 questions. This means that only questions 2, 3, 4a, 4b, 4d, 4e, 5, 6e, 6b, 7, 8b, 9, 12, 13a, 13c, and 13d of the EPIC-26 are administered. Utilization of Sexual Medications/Devices: The Utilization of Sexual Medications/Devices is free for all health care organizations, and a license is not needed. Refer to http://dx.doi.org/10.1016/j.urology.2006.01.077 for more information European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ- PR25): The EORTC QLQ-PR25 is free for all health care organizations, but a license is needed for use. Therefore it will not be integrated in this Version of the questionnaire. For more information, please visit http://groups.eortc.be/qol/eortc-qlq-c30 .
Link
Palavras-chave
Versões (2)
- 21/08/2018 21/08/2018 - Sarah Riepenhausen
- 30/04/2020 30/04/2020 - Sarah Riepenhausen
Titular dos direitos
ICHOM
Transferido a
21 de agosto de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
ICHOM Localized Prostate Cancer
Baseline Clinical Form
- StudyEvent: ODM
Descrição
Baseline Tumor Factors
Alias
- UMLS CUI-1
- C0475752
- UMLS CUI-2
- C1442488
Descrição
INCLUSION CRITERIA: All patients TIMING: Before treatment REPORTING SOURCE: Clinical or administrative data TYPE: Date by DD/MM/YYYY RESPONSE OPTIONS: DD/MM/YYYY
Tipo de dados
date
Alias
- UMLS CUI [1,1]
- C2316983
- UMLS CUI [1,2]
- C0679557
- UMLS CUI [1,3]
- C0600139
Descrição
INCLUSION CRITERIA: All patients TIMING: Before treatment REPORTING SOURCE: Clinical TYPE: Numerical value
Tipo de dados
float
Unidades de medida
- ng/mL
Alias
- UMLS CUI [1,1]
- C0138741
- UMLS CUI [1,2]
- C0332152
- UMLS CUI [1,3]
- C0679557
- UMLS CUI [1,4]
- C0600139
Descrição
Pathologic staging preferred, if available cT0: No evidence of primary tumor cT1: if not able to select cT1a, cT1b or cT1c: Clinically inapparent tumor neither palpable nor visible by imaging cT1a: Tumor incidental histologic finding in 5 percent or less of tissue resected cT1b: Tumor incidental histologic finding in more than 5 percent of tissue resected cT1c: Tumor identified by needle biopsy (eg, because of elevated PSA) cT2: if not able to select cT2a, cT2b or cT2c: Tumor confined within prostate* cT2a: Tumor involves one-half of one lobe or less cT2b: Tumor involves more than one-half of one lobe but not both lobes cT2c: Tumor involves both lobes cT3: if not able to select cT3a, cT3b or cT3c: Tumor extends through the prostate capsule cT3a: Extracapsular extension (unilateral or bilateral) cT3b: Tumor invades seminal vesicle(s) cT4: Tumor is fixed or invades adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscles, and/or pelvic wall cTX: Primary tumor cannot be assessed INCLUSION CRITERIA: All patients TIMING: Before treatment REPORTING SOURCE: Clinical TYPE: Single answer
Tipo de dados
integer
Alias
- UMLS CUI [1,1]
- C0441915
- UMLS CUI [1,2]
- C0205210
- UMLS CUI [1,3]
- C0600139
Descrição
Pathologic staging preferred, if available cNo: regional lymph node metastasis cN1: Metastasis in regional lymph node(s) cNX: Regional lymph nodes were not assessed INCLUSION CRITERIA: All patients TIMING: Before treatment REPORTING SOURCE: Clinical TYPE: Single answer
Tipo de dados
integer
Alias
- UMLS CUI [1,1]
- C0456532
- UMLS CUI [1,2]
- C0441915
- UMLS CUI [1,3]
- C0205210
- UMLS CUI [1,4]
- C0600139
Descrição
INCLUSION CRITERIA: All patients TIMING: Before treatment REPORTING SOURCE: Clinical TYPE: Numerical value
Tipo de dados
integer
Alias
- UMLS CUI [1,1]
- C1275862
- UMLS CUI [1,2]
- C0600139
Descrição
INCLUSION CRITERIA: All patients TIMING: Before treatment REPORTING SOURCE: Clinical TYPE: Numerical
Tipo de dados
integer
Alias
- UMLS CUI [1,1]
- C4528268
- UMLS CUI [1,2]
- C0600139
Descrição
INCLUSION CRITERIA: All patients TIMING: Before treatment REPORTING SOURCE: Clinical TYPE: Numerical value
Tipo de dados
integer
Unidades de medida
- %
Alias
- UMLS CUI [1]
- C1272841
Descrição
INCLUSION CRITERIA: All patients TIMING: Before treatment REPORTING SOURCE: Clinical TYPE: Numerical value
Tipo de dados
integer
Alias
- UMLS CUI [1,1]
- C1273604
- UMLS CUI [1,2]
- C0005558
Descrição
INCLUSION CRITERIA: All patients TIMING: Before treatment REPORTING SOURCE: Clinical TYPE: Numerical value
Tipo de dados
integer
Alias
- UMLS CUI [1,1]
- C1273605
- UMLS CUI [1,2]
- C0005558
Similar models
Baseline Clinical Form
- StudyEvent: ODM
C1442488 (UMLS CUI-2)
C0679557 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,3])
C0332152 (UMLS CUI [1,2])
C0679557 (UMLS CUI [1,3])
C0600139 (UMLS CUI [1,4])
C0205210 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,3])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0441915 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
C0600139 (UMLS CUI [1,4])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0600139 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,2])
C0005558 (UMLS CUI [1,2])
C0005558 (UMLS CUI [1,2])